Venus Remedies LimitedNSE: VENUSREM

Press Release Apr 25 2023

· Issued by Venus Remedies Limited

Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated April 25, 2023, titled " Venus Remedies secures Marketing Authorisation from UK MHRA for Cisplatin.".

View Attachment

6ix hasn’t read this filing yet.

Venus Remedies Limited on 6ix

Earlier from Venus Remedies

Later from Venus Remedies

All Venus Remedies news releases